Ordering
Available Variants5 mg
CHA.27952-5mg
Price
€81.60
Available – Dispatch in 14 days
25 mg
CHA.27952-25mg
Price
€304.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.27952-5mg | €81.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.27952-25mg | €304.00 |
≥98% (HPLC), ULK1 inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C22H16F4N4OS |
|---|---|
| CAS Number | 2443816-45-1 |
| Molecular Weight | 460.45 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD31813791 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
ULK-101, also known by its chemical abstracts service number 2443816-45-1, is a potent and selective inhibitor of the ULK1 enzyme, which plays a crucial role in the regulation of autophagy. Autophagy is a cellular process responsible for the degradation and recycling of damaged or dysfunctional cellular components. By inhibiting ULK1, ULK-101 has been shown to effectively block autophagy, making it a valuable tool for studying the role of autophagy in various diseases, including cancer and neurodegenerative disorders. The compound has been used in numerous research studies to investigate the molecular mechanisms underlying autophagy and its relationship to disease pathology. As a result, ULK-101 has contributed significantly to our understanding of autophagy and its potential as a therapeutic target for the treatment of various diseases. Further research is needed to fully explore the potential of ULK-101.
